Allergic conjunctivitis

Trials

50 participants · First posted Jan 5, 2021

Unknown

NCT04299399

Corneal Biomechanical Changes of Allergic Conjunctivitis

100 participants · First posted Mar 6, 2020

Active, not recruiting

NCT07385495

OJO-miR: microRNA Expression in Allergic Conjunctivitis.

40 participants · First posted Feb 4, 2026

Drugs

View all 279 →

Small Molecule

Approved

Nedocromil(Alocril)

Manufacturer: King pharmaceuticals inc, Allergan inc +1 more

Conditions: Allergic Rhinitis (AR), Asthma +1 more

C₁₉H₁₇NO₇ · Rx

Small Molecule

Approved

Carbinoxamine(Karbinal, Ryvent)

Manufacturer: Mcneil pharmaceutical co div mcneilab inc, Boca pharmacal inc +4 more

Conditions: Allergic Conjunctivitis (AC), Allergic Reaction +6 more

C₁₆H₁₉ClN₂O

Small Molecule

Approved

Epinastine(Elestat)

Manufacturer: Allergan inc

Conditions: Allergic Conjunctivitis (AC)

C₁₆H₁₅N₃ · Rx

Organizations

View all 37 →

Third Harmonic Bio

United States

Gossamer Bio

United States

Xencor

United States

Trials

Sea Water in Allergic Conjunctivitis

Corneal Biomechanical Changes of Allergic Conjunctivitis

OJO-miR: microRNA Expression in Allergic Conjunctivitis.

Drugs

Nedocromil(Alocril)

Carbinoxamine(Karbinal, Ryvent)

Epinastine(Elestat)

Organizations

Third Harmonic Bio

Gossamer Bio

Xencor

News

Nicox's ZERVIATE Approved in China for Allergic Conjunctivitis

Dextenza Insert Shows Strong Efficacy in Allergic Conjunctivitis Phase 3 Trial

Nanomerics' OC134 Eye Drop Receives MHRA Authorization for Clinical Trials in Allergic Conjunctivitis